Table 2.
Primary indications for cesarean delivery among HIV-infected women with documented indication for cesarean delivery (N=2,886)
| Indications for cesarean delivery | ||||||
|---|---|---|---|---|---|---|
| Characteristic | HIV infection (N=977) |
Arrest disorder (N=380) |
Maternal indication (N=94) |
Fetal indication (N=661) |
Repeat cesarean delivery (N=774) |
|
| N (%) | N (%) | N (%) | N (%) | N (%) | ||
| Guideline Period | 1998–1999 | 153 (32%) | 82 (17%) | 17 (4%) | 153 (32%) | 73 (15%)* |
| 2000–2008 | 710 (40%) | 202 (11%) | 56 (3%) | 381 (22%) | 413 (23%) | |
| 2009–2013 | 114 (18%) | 96 (15%) | 21 (3%) | 127 (20%) | 288 (45%) | |
| HAART Period | Early (1998–2008) | 863 (39%) | 284 (13%) | 73 (3%) | 534 (24%) | 486 (22%)* |
| Late (2009–2013) | 114 (18%) | 96 (15%) | 21 (3%) | 127 (20%) | 288 (45%) | |
| Last plasma viral load before delivery (copies/ml) | <1,000 | 493 (25%) | 331 (16%) | 60 (3%) | 503 (25%) | 624 (31%)* |
| ≥1,000 | 453 (58%) | 33 (4%) | 32 (4%) | 127 (16%) | 132 (17%) | |
| Unknown | 31 (32%) | 16 (16%) | 2 (2%) | 31 (32%) | 18 (18%) | |
| Ruptured membranes in labor | No | 866 (39%) | 167 (8%) | 84 (4%) | 424 (19%) | 671 (30%)* |
| Yes | 87 (15%) | 200 (34%) | 7 (1%) | 215 (36%) | 81 (14%) | |
| Unknown | 0 | 13 (22%) | 3 (5%) | 22 (37%) | 22 (37%) | |
| Gestational age at delivery (weeks) | <37 | 111 (20%) | 48 (9%) | 57 (10%) | 218 (39%) | 118 (21%)* |
| ≥37 | 866 (37%) | 332 (14%) | 37 (2%) | 443 (19%) | 653 (28%) | |
| Unknown | 0 | 0 | 0 | 0 | 3 (100%) | |
*
Reflects statistically significant findings with a p-value<0.001. A Chi-square test was used, which tested the difference in indication for cesarean delivery by strata.
This table is a subset of the 2,886 women with an available indication for cesarean delivery among the women who had a cesarean delivery in this cohort (n=3,025).